FDA approval

Cop 1 (Copaxone®): The Story of a Drug

Cop 1 (Copaxone®): The Story of a Drug

01.05.1997

Disease, Drugs & Diagnostics

Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

23.12.1996

Disease, Drugs & Diagnostics

REHOVOT, Israel -- December 23, 1996 -- The U.S. Food and Drug Administration today announced the approval of the Israeli...

New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee

New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee

19.09.1996

Disease, Drugs & Diagnostics

REHOVOT, Israel -- September 19, 1996 -- An advisory committee convened by the U.S. Food and Drug Administration...

Top Stories

Ben Kelmer Studio

New Eyes on the Sky

Dr. Gili Rosenberg

Dr. Gili Rosenberg

Prof. Daniel Zajfman

Prof. Daniel Zajfman

Prof. Michal Schwartz

Israel Prize in Life Sciences to Prof. Michal Schwartz

Press Releases

Treating a Heart Attack before It Happens

The Weight of Responsibility: Biomass of Livestock Dwarfs That of Wild Mammals

The Quantum Twisting Microscope: A New Lens on Quantum Materials

Most Popular Articles

One Protein, Two Programs

A cell’s decision to commit suicide involves an exchange of information between two suicide mechanisms

Checking the Dosage

Prof. Yoram Groner is a pioneer in Down syndrome research

The Limits of Computing

Computers can solve complex problems but they are far from omnipotent. Prof. Ran Raz of the Weizmann Institute's Computer Science and Applied Mathematics Department is trying to portray the limits...